机构：[1]Department of Otorhinolaryngology Head and Neck Surgery, Zhongshan Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine, Zhongshan, 528400, Guangdong, China.深圳市中医院深圳医学信息中心
第一作者机构：[1]Department of Otorhinolaryngology Head and Neck Surgery, Zhongshan Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine, Zhongshan, 528400, Guangdong, China.
通讯作者：
推荐引用方式(GB/T 7714)：
Huang Guan-Jiang.Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis.[J].European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery.2022,doi:10.1007/s00405-022-07394-8.
APA：
Huang Guan-Jiang.(2022).Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis..European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery,,
MLA：
Huang Guan-Jiang."Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis.".European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery .(2022)
